Gainers
- Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of Rhythm Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $388.0 million.
- GT Biopharma (NASDAQ:GTBP) shares moved upwards by 12.11% to $3.61. As of 12:30 EST, this security is trading at a volume of 330.7K shares, making up 140.7% of its average full-day volume over the last 100 days. The company's market cap stands at $110.4 million.
- Also check out: Insiders Sell More Than $92M Of 4 Stocks
- Bellicum Pharmaceuticals (NASDAQ:BLCM) shares increased by 11.94% to $1.78. The market value of their outstanding shares is at $14.9 million.
- Masimo (NASDAQ:MASI) shares increased by 10.89% to $159.91. As of 12:30 EST, this security is trading at a volume of 1.9 million shares, making up 424.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.8 billion. As per the press release, Q4 earnings came out 2 days ago.
- Catalyst Biosciences (NASDAQ:CBIO) shares increased by 9.72% to $0.57. Trading volume for Catalyst Biosciences's stock is 1.2 million as of 12:30 EST. This is 127.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.8 million.
- Citius Pharmaceuticals (NASDAQ:CTXR) shares moved upwards by 9.03% to $1.81. Citius Pharmaceuticals's stock is trading at a volume of 2.0 million shares as of 12:30 EST. This is 129.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $264.3 million.
Losers
- Marker Therapeutics (NASDAQ:MRKR) shares decreased by 24.9% to $0.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 201.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.5 million. As per the press release, Q4 earnings came out yesterday.
- Yumanity Therapeutics (NASDAQ:YMTX) stock declined by 17.52% to $1.46. Trading volume for Yumanity Therapeutics's stock is 197.8K as of 12:30 EST. This is 175.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.0 million.
- Zynex (NASDAQ:ZYXI) stock fell 17.41% to $5.98. As of 12:30 EST, this security is trading at a volume of 951.2K shares, making up 309.1% of its average full-day volume over the last 100 days. The company's market cap stands at $239.7 million.
- Hillstream BioPharma (NASDAQ:HILS) shares declined by 16.67% to $2.05. As of 12:30 EST, this security is trading at a volume of 271.0K shares, making up 30.5% of its average full-day volume over the last 100 days. The company's market cap stands at $23.0 million.
- Poseida Therapeutics (NASDAQ:PSTX) stock fell 12.59% to $3.68. Trading volume for this security as of 12:30 EST is 157.4K, which is 98.1% of its average full-day volume over the last 100 days. The company's market cap stands at $230.0 million.
- Tempest Therapeutics (NASDAQ:TPST) shares decreased by 12.51% to $3.15. The market value of their outstanding shares is at $21.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
